Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis

Figure 6

Expression and prognostic value of MAD2L1 in HCC. (a–e) The expression data collected from 4 datasets from ONCOMINE indicated that MAD2L1 expression was upregulated in HCC tissues compared with the normal controls (all ). (f) Expression of MAD2L1 was increased in HCC cells based on the data from CCLE. (g) The Kaplan-Meier survival curves revealed that the high MAD2L1 expression predicted worse overall survival compared with the low MAD2L1 expression in HCC patients (log-rank ). (h) High MAD2L1 expression predicted worse overall survival compared with the low MAD2L1 expression in patients with HCC at tumor stage 1 (log-rank ). (i) High MAD2L1 expression predicted worse overall survival compared with the low MAD2L1 expression in HCC patients at tumor stage 2 (log-rank ). (j) High MAD2L1 expression predicted worse overall survival compared with the low MAD2L1 expression in patients with HCC at tumor stage 3 (log-rank ).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)